Natasha Patel

Natasha Patel is a skilled professional in bioprocess development with extensive experience in various roles within the biotechnology and pharmaceutical industries. Currently serving as Manager of CMC Process Development at CG Oncology since August 2025, Natasha previously held positions at Neurogene Inc. from October 2020 to August 2025, where contributions included the development of plasmid manufacturing and gene therapy platforms. Natasha's career also includes significant roles at FUJIFILM Diosynth Biotechnologies, Boehringer Ingelheim, and BioMarin Pharmaceutical Inc., focusing on the optimization and scale-up of multiple cell culture platforms, compliance with regulatory requirements, and data management. Educational credentials include a Bachelor's Degree in Microbiology and Immunology from the University of California, Merced, completed in 2015.